News from immunovia ab A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

27 May, 2020, 15:34 BST Immunovia Provides Forth Update During COVID-19 Pandemic

Immunovia AB (publ) ("Immunovia") today provides an update on the actions that the company is taking in response to the coronavirus (COVID-19)...


26 May, 2020, 03:58 BST Invitation to Immunovia's Update #4 on COVID-19 Company Response

Immunovia invites you to a teleconference (in English) for all stakeholders and media on Wednesday, May 27, 2020 at 16:30 CET. Mats Grahn, CEO will...


13 May, 2020, 15:19 BST Immunovia Provides Third Update During COVID-19 Pandemic

Immunovia AB (publ) ("Immunovia") today provides an update on the actions that the company is taking in response to the coronavirus (COVID-19)...


12 May, 2020, 17:27 BST Invitation to Immunovia's Update #3 on COVID-19 Company Response

Immunovia invites you to a teleconference (in English) for all stakeholders and media on Wednesday, May 13, 2020 at 16:30 CET. Mats Grahn, CEO will...


08 May, 2020, 12:25 BST Immunovia - Report From AGM

The Annual General Meeting (AGM) of Immunovia AB (publ), corporate identity number 556730-4299 was held in The Spark at Medicon Village,...


28 Apr, 2020, 15:27 BST Immunovia Reports First Quarter Interim Report January - March 2020

Immunovia has today published first quarter interim report for January - March 2020. It is available on Immunovia's website. "During Q1 2020,...


22 Apr, 2020, 16:50 BST Invitation to Presentation of Immunovia's Interim Report January - March 2020 on April 28, 2020

Immunovia invites to a teleconference (in English) for investors, analysts and media on Tuesday, April 28th, 2020 at 16:30 CET. Immunovia will...


08 Apr, 2020, 08:10 BST Immunovia and Global Pharmaceutical Company Agree on Early Termination of Lung Cancer Collaboration

Immunovia AB (publ) ("Immunovia") today announced that the company's Lung Cancer collaboration with a global pharmaceutical company has been...


01 Apr, 2020, 15:14 BST Immunovia Takes Action During COVID-19 Pandemic and Remains Focused on Launch of IMMray™ PanCan-d

Immunovia AB (publ) ("Immunovia") today provides an update on the actions that the company is taking to support patients, employees, and public...


30 Mar, 2020, 13:01 BST Invitation to a Company Update on the COVID-19 Response

Immunovia invites you to a teleconference (in English) for all stakeholders and media on Wednesday, April 1, 2020 at 16:30 CET. Mats Grahn, CEO will...


26 Mar, 2020, 13:25 GMT Board Member Hans Johansson Buys Immunovia Shares

Immunovia AB (publ) ("Immunovia") announced today that current Board Member, Hans Johansson, has acquired Immunovia shares for 500 KSEK on the open...


20 Mar, 2020, 07:52 GMT Immunovia Publishes the Annual Report for the Financial Year 2019

Immunovia has today published the annual report for 2019. It is available on Immunovia's website. Mats Grahn, CEO, comments: "In December 2019, we...


10 Feb, 2020, 17:03 GMT Invitation to Presentation of Immunovia's Full Year Report 2019 on February 14, 2020

Immunovia invites to a teleconference (in English) for investors, analysts and media on Friday, February 14th, 2020 at 8:30 am CET. Immunovia will...


26 Apr, 2019, 16:46 BST Immunovia - Report from AGM

The Annual General Meeting (AGM) of Immunovia AB (publ), corporate identity number 556730-4299 was held at Gamla Gästmatsalen in Medicon Village,...


24 Apr, 2019, 15:59 BST CORRECTION: Immunovia Interim Report, January-March 2019

(The previous release was sent at 10.23 CET and has been updated with accurate dates in the key indicators of the Swedish version. The correct dates...


24 Apr, 2019, 09:34 BST Immunovia Interim Report, January-March 2019

During the first quarter of 2019, we remained focused on our product launch strategy and continued to create value, as we reached several key...


10 Apr, 2019, 07:27 BST Corrected: Immunovia and University College of London Sign Agreement to Expand Validation Studies of IMMray™ PanCan-d for Early Signs and Symptoms

Immunovia today announced that Prof. Stephen Pereira and his team at the institute for Liver and Digestive Health, University College London (UCL)...


04 Mar, 2019, 09:11 GMT Immunovia Publishes the Annual Report for the Financial Year 2018

Immunovia has today published the annual report for 2018 in Swedish. It is available on Immunovia's website. Mats Grahn, CEO, comments: "We entered...


04 Mar, 2019, 07:17 GMT Immunovia Provides an Update on the Optimization Work to Meet the Expected Performance for Commercialization of IMMray™ PanCan-d

Immunovia AB (publ) ("Immunovia") today announced an update on the optimization process to refine the algorithms and eliminate any potential...


14 Feb, 2019, 16:34 GMT Immunovia Full Year Report, January-December 2018

Throughout 2018, we continued to build on our mission to develop and validate accurate bloodbased diagnostic tests that can make a real and...


14 Feb, 2019, 15:10 GMT Immunovia to Participate in Upcoming Investor Conferences in March

Immunovia AB today announced that Mats Grahn, Chief Executive Officer, will participate and host one-on-one investor meetings at the following...


12 Feb, 2019, 14:09 GMT Invitation to Presentation of Immunovia´s Full Year Report 2018 on February 14, 2019

Immunovia invites to a teleconference (in English) for investors, analysts and media on February 14, at 5:30 – 6:30 p.m. CET. Immunovia will publish...


12 Feb, 2019, 13:18 GMT Immunovia AB Announces Appointment of Senior Director of Investor Relations

(Nasdaq Stockholm: IMMNOV), to strengthen IR and shareholder communication Immunovia today announced that Julie Silber has joined as Director of...


13 Nov, 2018, 13:56 GMT Immunovia Invited to Present at Jefferies 2018 London Healthcare Conference

Immunovia (Nasdaq Stockholm: IMMNOV), today announced that the Company has been invited to present at the Jefferies 2018 London Healthcare Conference ...


13 Nov, 2018, 11:27 GMT McGill, Yale and Universities of Pennsylvania and Massachusetts Join PanFAM-1, the Largest Ever Prospective Multicenter Clinical Study for Early Detection of Pancreatic Cancer

Immunovia AB today announced that four additional North American Familial Pancreatic Cancer (FPC) sites are to participate in PanFAM-1, the largest...